beer with grains

(Credit: id-art/Shutterstock)

In A Nutshell

  • Drinking nearly two standard drinks per day is linked to a 10% to 30% higher risk of pancreatic cancer, according to a large analysis of more than 20 million people.
  • No level of alcohol consumption showed any protective effect against the disease.
  • Past studies that appeared to show moderate drinking was safe were likely skewed by a research flaw that made current drinkers look healthier than they actually were.
  • For every additional 10 grams of pure alcohol consumed daily, pancreatic cancer risk rose by roughly 2.4%.

Pancreatic cancer is one of the deadliest cancers in the world, and it’s notoriously hard to catch early. Now, a large new analysis of decades of research finds that drinking nearly two standard drinks’ worth of alcohol per day is significantly linked to a higher risk of developing it. Moreover, previous studies may have been giving a misleadingly rosy picture of what moderate drinking does to the pancreas, thanks to a longstanding flaw in how alcohol research has been conducted.

Published in the International Journal of Alcohol and Drug Research, the analysis pooled data from 37 cohort analyses drawn from 23 published studies covering more than 20 million people and more than 65,000 cases of pancreatic cancer. A consistent pattern emerged: the more alcohol a person drinks, the higher their associated risk. Drinking above 24 grams of pure alcohol per day, nearly two standard U.S. drinks, was associated with a 10% to 30% increased risk of pancreatic cancer. No level of drinking appeared to offer any protection against the disease.

A Hidden Flaw in Alcohol and Pancreatic Cancer Research

For years, studies on alcohol and health produced a puzzling pattern: light to moderate drinkers often seemed to have lower rates of certain diseases than people who didn’t drink at all. Researchers call this a J-shaped curve, where risk appears to drop at low consumption levels before rising again with heavier drinking. Some earlier analyses of pancreatic cancer found the same shape, suggesting that a drink or two might actually be protective.

This new analysis argues that pattern is largely a statistical illusion produced by a research mistake called “former drinker bias.” Many studies group people who have never drunk alcohol together with people who used to drink but quit. Former drinkers may quit because of health problems, and as a group they tend to be less healthy than lifetime abstainers. When that less-healthy group gets folded into the “non-drinker” comparison group, current drinkers look relatively healthier by comparison, even when they’re not.

When the researchers focused on studies that had carefully kept true lifetime non-drinkers separate from former drinkers, the apparent protective effect at low and moderate drinking levels disappeared entirely. Light drinking showed no clear protective effect, while higher intake was linked to higher risk. Studies that still carried the former drinker flaw, meanwhile, continued to show that apparent dip in risk for moderate drinkers, a pattern the authors argue should no longer be trusted.

Responsible for about 50,000 American deaths annually, pancreatic cancer is considered one of the most stubborn forms of the disease.
New research finds nearly two drinks a day raises pancreatic cancer risk up to 30% and earlier studies may have gotten it wrong. (Credit: Jo Panuwat D on Shutterstock)

Researchers Pooled Data From 20 Million People Across Decades of Studies

The research team searched two major scientific databases for studies published up to January 1, 2024. They focused on cohort studies, which follow large groups of people over time to track who develops a disease and who doesn’t, a design generally considered more reliable for this type of question than studies that only look backward after someone gets sick.

After screening thousands of records, they narrowed the field to 37 cohort analyses drawn from 23 published studies. Together, those studies tracked more than 20.7 million people and recorded over 65,000 pancreatic cancer diagnoses or deaths. Three independent reviewers extracted data from each study, and the lead investigators resolved any disagreements.

Alcohol consumption was measured in grams of pure alcohol per day and divided into categories, from very light drinkers consuming up to 4 grams a day to the heaviest drinkers consuming more than 64 grams daily. For reference, a standard U.S. drink contains roughly 14 grams of pure alcohol. Participants were classified as lifetime non-drinkers, former drinkers, or current drinkers. The team then tested how much the results shifted depending on whether individual studies had made careful distinctions between those groups.

Risk Climbs Up to 30% for People Drinking Nearly Two Drinks a Day

A consistent dose-response relationship emerged: the more alcohol consumed, the higher the risk, in a steady and measurable pattern. For every additional 10 grams of pure alcohol per day, pancreatic cancer risk rose by approximately 2.4%.

Drinking in the range of 24 to 44 grams per day was associated with roughly 8% to 21% higher risk, depending on the model used. Heavier drinking pushed the risk higher still. At the heaviest levels studied, risk climbed 14% to 28% above that of lifetime non-drinkers.

Alcohol Triggers Inflammation and Releases Cancer-Causing Chemicals in the Pancreas

Researchers have several plausible explanations for why alcohol could affect the pancreas. Alcohol is a recognized cause of pancreatitis, painful inflammation of the pancreas that is itself a known risk factor for pancreatic cancer. When the body breaks down alcohol, it produces a chemical called acetaldehyde, a known cancer-causing substance. Alcohol may also damage the pancreas through other chemical pathways and may weaken the immune system in ways that allow cancer to develop more easily.

Pancreatic cancer remains one of the deadliest cancers precisely because it is so often diagnosed too late. When the data are examined with methodological flaws accounted for, alcohol consumption and pancreatic cancer risk move consistently in the same direction. In the authors’ view, the old idea that a drink or two might offer some protection looks far more like a byproduct of flawed research design than any genuine biological benefit.


Disclaimer: This article is based on observational research, which can identify associations but cannot prove direct cause and effect. The findings reflect population-level patterns and may not apply to every individual. Consult a qualified healthcare provider with any questions about alcohol use and personal health risk.


Paper Notes

Limitations

The meta-analysis drew on 37 cohort analyses containing 279 risk estimates, which the authors describe as a relatively small sample, particularly for more complex models adjusted for multiple study-level characteristics. This may have reduced the precision of the risk estimates. Only cohort studies were included; case-control studies, which may capture different aspects of the alcohol-cancer relationship, were not incorporated. The analysis assessed only average daily alcohol intake and did not account for drinking patterns such as binge drinking, as very few included studies tracked that variable. Differential effects from different types of alcoholic beverages were not considered. The number of factors that individual studies controlled for varied widely, ranging from one to eleven, meaning that unmeasured influences in individual studies could not be fully accounted for in the pooled analysis.

Funding and Disclosures

Financial support for this study was provided by the Canadian Institute for Substance Use Research (CISUR) of University of Victoria Endowment Fund. The authors declared no conflicts of interest.

Publication Details

Authors: Jinhui Zhao, Tim Stockwell, Timothy S. Naimi, James M. Clay, Keegan Lawrence, and Adam Sherk. All authors are affiliated with the Canadian Institute for Substance Use Research, University of Victoria, BC, Canada. Additional affiliations include the Psychology Department and School of Medical Sciences at the University of Victoria; the Department of Community Health and Epidemiology at Dalhousie University, Nova Scotia, Canada; and the Canadian Centre on Substance Use and Addiction, Ottawa, ON, Canada. | Journal: International Journal of Alcohol and Drug Research (IJADR), the official journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol. ISSN: 1925-7066. Volume 14, 2026. | Paper Title: “Alcohol consumption and the risk of pancreatic cancer: A systematic review and meta-analysis of cohort studies” | DOI: https://doi.org/10.7895/ijadr.649

About StudyFinds Analysis

Called "brilliant," "fantastic," and "spot on" by scientists and researchers, our acclaimed StudyFinds Analysis articles are created using an exclusive AI-based model with complete human oversight by the StudyFinds Editorial Team. For these articles, we use an unparalleled LLM process across multiple systems to analyze entire journal papers, extract data, and create accurate, accessible content. Our writing and editing team proofreads and polishes each and every article before publishing. With recent studies showing that artificial intelligence can interpret scientific research as well as (or even better) than field experts and specialists, StudyFinds was among the earliest to adopt and test this technology before approving its widespread use on our site. We stand by our practice and continuously update our processes to ensure the very highest level of accuracy. Read our AI Policy (link below) for more information.

Our Editorial Process

StudyFinds publishes digestible, agenda-free, transparent research summaries that are intended to inform the reader as well as stir civil, educated debate. We do not agree nor disagree with any of the studies we post, rather, we encourage our readers to debate the veracity of the findings themselves. All articles published on StudyFinds are vetted by our editors prior to publication and include links back to the source or corresponding journal article, if possible.

Our Editorial Team

Steve Fink

Editor-in-Chief

John Anderer

Associate Editor

Leave a Comment